Chen C, Li F, Montelaro R C
Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, USA.
J Virol. 2001 Oct;75(20):9762-70. doi: 10.1128/JVI.75.20.9762-9770.2001.
Previous studies utilizing Gag polyprotein budding assays with transfected cells reveal that the equine infectious anemia virus (EIAV) Gag p9 protein provides a late assembly function mediated by a critical Y(23)P(24)D(25)L(26) motif (L-domain) to release viral particles from the plasma membrane. To elucidate further the role of EIAV p9 in virus assembly and replication, we have examined the replication properties of a defined series of p9 truncation and site-directed mutations in the context of a reference infectious molecular proviral clone, EIAV(uk). Characterization of these p9 proviral mutants revealed new functional properties of p9 in EIAV replication, not previously elucidated by Gag polyprotein budding assays. The results of these studies demonstrated that only the N-terminal 31 amino acids of a total of 51 residues in the complete p9 protein were required to maintain replication competence in transfected equine cells; proviral mutants with p9 C-terminal truncations of 20 or fewer amino acids remained replication competent, while mutants with truncations of 21 or more residues were completely replication defective. The inability of the defective p9 proviral mutations to produce infectious virus could not be attributed to defects in Gag polyprotein expression or processing, in virion RT activity, or in virus budding. While proviral replication competence appeared to be associated with the presence of a K(30)K(31) motif and potential ubiquitination of the EIAV p9 protein, mutations of these lysine residues to methionines produced variant proviruses that replicated as well as the parental EIAV(uk) in transfected ED cells. Thus, these observations reveal for the first time that EIAV p9 is not absolutely required for virus budding in the context of proviral gene expression, suggesting that other EIAV proteins can at least in part mediate late budding functions previously associated with the p9 protein. In addition, the data define a function for EIAV p9 in the infectivity of virus particles, indicating a previously unrecognized role for this Gag protein in EIAV replication.
先前利用转染细胞进行的Gag多聚蛋白出芽试验的研究表明,马传染性贫血病毒(EIAV)Gag p9蛋白通过关键的Y(23)P(24)D(25)L(26)基序(L结构域)介导晚期组装功能,以从质膜释放病毒颗粒。为了进一步阐明EIAV p9在病毒组装和复制中的作用,我们在参考感染性分子原病毒克隆EIAV(uk)的背景下,研究了一系列特定的p9截短和定点突变的复制特性。这些p9原病毒突变体的特征揭示了p9在EIAV复制中的新功能特性,这是先前Gag多聚蛋白出芽试验未阐明的。这些研究结果表明,在转染的马细胞中维持复制能力仅需要完整p9蛋白总共51个残基中的N端31个氨基酸;p9 C端截短20个或更少氨基酸的原病毒突变体仍具有复制能力,而截短21个或更多残基的突变体则完全复制缺陷。有缺陷的p9原病毒突变体无法产生感染性病毒,这不能归因于Gag多聚蛋白表达或加工、病毒粒子RT活性或病毒出芽方面的缺陷。虽然原病毒复制能力似乎与K(30)K(31)基序的存在以及EIAV p9蛋白的潜在泛素化有关,但将这些赖氨酸残基突变为甲硫氨酸产生的变异原病毒在转染的ED细胞中的复制情况与亲本EIAV(uk)相同。因此,这些观察结果首次揭示,在原病毒基因表达的背景下,病毒出芽并非绝对需要EIAV p9,这表明其他EIAV蛋白至少可以部分介导先前与p9蛋白相关的晚期出芽功能。此外,数据确定了EIAV p9在病毒粒子感染性方面的功能,表明该Gag蛋白在EIAV复制中具有先前未被认识的作用。